Literature DB >> 11114500

The tumour necrosis factor receptor family: life or death choices.

E Y Jones1.   

Abstract

The past twelve months have seen a renewal of interest in the therapeutic potential of members of the tumour necrosis factor receptor family and their cytokine ligands. This biomedical interest has spawned a number of structural studies, which have significantly deepened our understanding of the molecular basis for the function of these cell-surface signalling systems. The fresh data have revealed unexpected mechanisms conferring ligand-receptor specificity and have highlighted the structural requirements for the initiation of intracellular signalling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114500     DOI: 10.1016/s0959-440x(00)00149-4

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  3 in total

1.  A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

Authors:  Kazuhiro Aoki; Hiroaki Saito; Cecile Itzstein; Masaji Ishiguro; Tatsuya Shibata; Roland Blanque; Anower Hussain Mian; Mariko Takahashi; Yoshifumi Suzuki; Masako Yoshimatsu; Akira Yamaguchi; Pierre Deprez; Patrick Mollat; Ramachandran Murali; Keiichi Ohya; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2006-05-04       Impact factor: 14.808

2.  Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity.

Authors:  J Lam; C A Nelson; F P Ross; S L Teitelbaum; D H Fremont
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone.

Authors:  Liam Bell; Janique M Peyper; Shaun Garnett; Rabecca Tadokera; Robert Wilkinson; Graeme Meintjes; Jonathan M Blackburn
Journal:  Exp Mol Pathol       Date:  2017-02-14       Impact factor: 3.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.